跳至主要内容
临床试验/CTRI/2020/03/024384
CTRI/2020/03/024384尚未招募未知

Evaluation of Efficacy and Safety of Benidipine, Amlodipine and Telmisartan in Patients of Hypertention- A Comparative Study.

AIIMS Patna0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Newly diagnosed hypertensive patient.
  • 2)Age: >=30 years to < 60 years.
  • 3)BMI: >18.5 to < 30 kg/m2.
  • 4)Sex: Both.
  • 5)Systolic Blood Pressure: >=140 to <=160 mmHg.
  • 6)Diastolic Blood Pressure: >=90 to <100 mmHg.

排除标准

  • 1)Age: <30yrs to >=60yrs.
  • 2)BMI: <18.5 to >30 kg/m2.
  • 3)Patients diagnosed with secondary hypertension.
  • 4)Patients with renal disease (serum creatinine >1.2).
  • 5)Patients with any history of drug allergies with anti-hypertensive agents.
  • 6)Patients on any other anti-hypertensive drugs (ACEI/DIURETICS/BETA-BLOCKERS).
  • 7)Patients with liver diseases (ALT/AST < 40IU)
  • 8)Patients with pre-existing pedal edema, hypoproteinemia, and Nephrotic syndrome.
  • 9)Patients with any other chronic illness (Diabetes, Rheumatoid arthritis, Tuberculosis).
  • 10)On long term NSAID and steroids.
  • 11)Patients with unsound mind and drug addicts.
  • 12)Pregnant and lactating women.
  • 13)Patient not willing to give consent.

研究者

发起方
AIIMS Patna

相似试验

Evaluation of efficacy (reduction of blood pressure)... | 临床试验